Co-Dx is pleased with the productive engagement with the FDA related to the initial regulatory submission and with the performance of the test in clinical evaluations, including performance data and ...

Tuberculosis (TB) has long been recognized as a disease of poverty, yet most TB research does not measure poverty in a ...

Indeed, the pathogen seems like ancient history — but as recent developments indicate, tuberculosis isn’t done with us yet.

A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials.

Hims & Hers, a health and wellness platform, is set to introduce at-home lab testing capabilities through the acquisition of ...

The U.S. President's Emergency Plan for AIDS Relief (PEPFAR) contributed US$15.6 million to the HIV response in Ukraine during 2023 and 2024. This includes $11 million for antiretroviral therapy and ...

A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials ...

Many Americans have turned to Hims & Hers and other telehealth companies for copies of weight-loss drugs after struggling to ...

David Ussery and Brian Delavan discuss bioinformatics into TB surveillance, presenting a new approach to tackling this ...